# Quality Score Report: BARRIER-2 Handoff (RED to ENG) — Iteration 3 (Revised)

## L0 Executive Summary

**Score:** 0.901/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Evidence Quality (0.88)
**One-line assessment:** Iteration 3 resolved all five priority improvements from v2 — registration output paths, disposition criteria with RPN thresholds, QG-R2 artifact path, OPEN finding priority ordering (correctly descending by RPN), and SEC-008 explicit priority — raising the composite from 0.857 to 0.901, with only minor residual gaps (QG-E3 "structurally verified" undefined, SEC-009 missing RPN value, "—" VULN ID convention unexplained, three OPEN findings missing explicit ACCEPTED-RISK recommendations) standing 0.019 below the 0.92 threshold.

**Correction note:** A prior draft of this score report (v3 draft) incorrectly identified a priority-ordering inconsistency in the Blockers section. The current barrier-handoff.md lists findings in correct descending-RPN order: SEC-011 (160), SEC-008 (144), SEC-005 (96), SEC-010 (72), SEC-007 (64), SEC-012 (48). That finding was a false positive scored against an intermediate document state. This revised report reflects the current document.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-0039-nuclear-engineer/orchestration/nuclear-sop-build-20260325-001/cross-pollination/barrier-2/red-to-eng/barrier-handoff.md`
- **Deliverable Type:** Synthesis (cross-pipeline handoff document)
- **Criticality Level:** C3
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Iteration:** 3 (prior scores: v1=0.793, v2=0.857)
- **Scored:** 2026-04-13

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.901 |
| **Prior Score (Iteration 2)** | 0.857 |
| **Score Delta** | +0.044 |
| **Threshold** | 0.92 (H-13) |
| **Gap to Threshold** | -0.019 |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.90 | 0.180 | Registration output paths and QG-E5 conditions resolved; minor gap: QG-E3 "structurally verified" qualifier undefined |
| Internal Consistency | 0.20 | 0.90 | 0.180 | QG-R2 artifact path added; ACCEPTED-RISK descriptors present; SEC-009 still missing RPN value (stylistic inconsistency) |
| Methodological Rigor | 0.20 | 0.90 | 0.180 | Disposition criteria with RPN thresholds fully specified; priority ordering correct and annotated; SEC-005/007/010 missing explicit ACCEPTED-RISK labels |
| Evidence Quality | 0.15 | 0.88 | 0.132 | QG-R2 now traceable; Tool Tier claim cites section name but no inline artifact path; "—" VULN ID convention unexplained |
| Actionability | 0.15 | 0.92 | 0.138 | All three v2 actionability gaps resolved: output paths, decision criteria, priority order; no blocking gaps remain |
| Traceability | 0.10 | 0.91 | 0.091 | QG-R2 artifact path closes RED Phase 2 chain break; "—" VULN ID convention not footnoted; QG-V1/V2 label inconsistency |
| **TOTAL** | **1.00** | | **0.901** | |

---

## Detailed Dimension Analysis

### Completeness (0.90/1.00)

**Evidence of improvement (since v2):**

*Gap A resolved (Priority 1 from v2):* Expected Output now has four entries (lines 111-116). Three registration staging files are now specified with full paths:
- `eng/phase-6/eng-reviewer-001/registration-trigger-map-row.md`
- `eng/phase-6/eng-reviewer-001/registration-claude-md-entry.md`
- `eng/phase-6/eng-reviewer-001/registration-agents-md-entries.md`

A P-020 registration workflow note was added explaining that staging files are produced by eng-reviewer-001 and applied by the user after QG-E6, providing the authorization-to-deploy boundary that was absent in v2.

*Gap C resolved:* Success Criteria now has a dedicated entry #5 explicitly covering QG-E5 CONDITIONAL PASS conditions: "(a) SEC-008 remediation applied or dispositioned, (b) QG-E4 pre-ship gate status documented." This was previously implicit in Success Criterion #4.

**Remaining gaps:**

*Gap A (minor): QG-E3 "structurally verified" qualifier undefined.* The artifact table still notes QG-E3 as "structurally verified; 004a 0.94, 004b 0.93." The methodology for "structural verification" as distinct from a numeric QG score is not defined anywhere in the handoff document.

*Gap B (cosmetic): "—" VULN ID convention undocumented.* Nine of fourteen SEC findings carry "—" in the VULN ID column without a footnote explaining the convention.

**Improvement Path:**
Add a definition for "structurally verified" (one sentence). Add a footnote: "— = ENG-originated finding with no RED team counterpart."

---

### Internal Consistency (0.90/1.00)

**Evidence of improvement (since v2):**

*QG-R2 artifact path added (Priority 3 from v2):* Line 49 now reads: "RED Phase 2 recon output (QG-R2: 0.932 PASS, score at `red/phase-2/red-recon-001/qg-r2-score.md`)." QG-R2 is now verifiable; the concern about identical scores (QG-R2 and QG-R3 both at 0.932) being a copy-paste error is resolved by the presence of a distinct artifact path.

*ACCEPTED-RISK descriptors present:* All ACCEPTED-RISK rows have residual risk content: SEC-004 ("FM-05 RPN 192 (irreducible)"), SEC-006 ("RPN 48 (safe defaults)"), SEC-009 ("Shares FM-05 root cause"), SEC-013 ("RPN 15 (low impact)"), SEC-014 ("RPN 15 (low impact)").

*Priority ordering correct and consistent with stated criteria:* The Blockers section states "ordered by priority (descending current RPN)" and the actual order is: SEC-011 (160), SEC-008 (144), SEC-005 (96), SEC-010 (72), SEC-007 (64), SEC-012 (48). This is correct descending-RPN order. The REMEDIATE and DEFERRED recommendations provided (SEC-011 REMEDIATE, SEC-008 REMEDIATE, SEC-012 DEFERRED) are consistent with the stated RPN thresholds (>100 = REMEDIATE, <50 = DEFERRED).

**Remaining gaps:**

*Gap A (minor): SEC-009 Residual Risk column lacks RPN.* "Shares FM-05 root cause" does not include an RPN value. All other ACCEPTED-RISK rows show either "RPN {N}" or "FM-{N} RPN {N}" notation. SEC-004 at "FM-05 RPN 192 (irreducible)" is the closest comparable; SEC-009 should show its RPN value for consistency.

**Improvement Path:**
Add the RPN value for SEC-009: "Shares FM-05 root cause — RPN 192 (equivalent to FM-05)."

---

### Methodological Rigor (0.90/1.00)

**Evidence of improvement (since v2):**

*Gap A resolved (Priority 2 from v2 — disposition criteria):* The Blockers section now contains explicit RPN-threshold criteria:
- **REMEDIATE:** Current RPN > 100, OR finding blocks a QG-E5 CONDITIONAL PASS condition
- **ACCEPTED-RISK:** Current RPN 50-100 AND the proposed remediation is behavioral-only
- **DEFERRED:** Current RPN < 50 OR the finding requires infrastructure changes beyond current skill scope

These criteria are C3-calibrated and anchored to the FMEA methodology established in ENG Phase 5.

*Gap B resolved (Priority 5 from v2 — priority ordering):* OPEN findings are ordered by descending RPN: SEC-011 (160), SEC-008 (144), SEC-005 (96), SEC-010 (72), SEC-007 (64), SEC-012 (48). Recommendations are provided for three findings (SEC-011 REMEDIATE, SEC-008 REMEDIATE, SEC-012 DEFERRED). All recommendations are consistent with the stated criteria.

**Remaining gaps:**

*Gap A (minor): QG-E3 "structurally verified" methodology undefined.* The qualification remains unexplained. For eng-reviewer-001 to treat QG-E3 as passing in the compliance matrix, the basis for "structural verification" needs to be stated.

*Gap B (minor): SEC-005, SEC-007, SEC-010 lack explicit recommendations.* The priority list annotates SEC-011, SEC-008, and SEC-012 with explicit recommendations but SEC-005 (RPN 96), SEC-010 (RPN 72), and SEC-007 (RPN 64) appear without annotations. Applying the stated criteria, all three fall in the 50-100 ACCEPTED-RISK range. The criteria enable derivation, but explicit recommendations would complete methodological coverage for all six findings.

**Improvement Path:**
Define "structurally verified" in a note. Add explicit ACCEPTED-RISK recommendations for SEC-005, SEC-007, and SEC-010 for consistency with the treatment of the other three findings.

---

### Evidence Quality (0.88/1.00)

**Evidence of improvement (since v2):**

*Gap B largely resolved (QG-R2 evidence):* QG-R2 score artifact path now provided on line 49. The QG-R2 score (0.932 PASS) is now verifiable.

*Gap A partially resolved — Tool Tier claim:* Key Finding #4 now states "Zero violations per eng-security-001 security review Section 'Tool Tier Compliance' (security-review.md)." The reference names a specific section within the cited artifact, and the security-review.md artifact path is in the ENG Phase 5 table.

**Evidence quality by claim (v3):**

| Claim | Evidence | Quality |
|-------|----------|---------|
| Critical vulns have remediations applied | REMEDIATED status + specific file locations + post-remediation RPNs | Strong |
| High vulns unresolved | OPEN status + DREAD scores + SEC IDs | Strong |
| All prior QG passed | QG scores in artifact table + artifact paths to score files | Strong |
| Tool tier compliance CLEAN | Section name cited; artifact path via two-hop table lookup | Adequate (indirect) |
| QG-E5 CONDITIONAL PASS with two conditions | Conditions named + artifact path to qg-e5-score-v2.md | Adequate |
| QG-R2 passed at 0.932 | Artifact path to qg-r2-score.md provided | Adequate |
| "—" VULN ID convention | Not explained | Weak |

**Remaining gaps:**

*Gap A (minor): "Tool tier compliance CLEAN" — indirect evidence chain.* The evidence requires a two-hop inference: Key Finding #4 → "security-review.md Section Tool Tier Compliance" → find the path in ENG Phase 5 artifact table → read the section. Direct inline citation of the artifact path in Key Finding #4 would raise this to Strong.

*Gap B (minor): "—" VULN ID convention unexplained.* Nine of 14 findings have "—" VULN ID without a convention note, making the evidence chain for those findings technically incomplete.

**Improvement Path:**
Add the security-review.md artifact path inline in Key Finding #4. Add a footnote to the remediation table explaining the "—" VULN ID convention.

---

### Actionability (0.92/1.00)

**Evidence of improvement (since v2):**

All three v2 actionability gaps are resolved:

*Gap A resolved (Priority 1 from v2 — registration output paths):* Expected Output now contains four rows with full staging file paths. The P-020 workflow note specifies: staging files produced by eng-reviewer-001, applied to live files by user after QG-E6, per `user_authority: true`. The receiving agent has unambiguous output destinations and clear authority boundaries.

*Gap B resolved (Priority 2 from v2 — disposition decision criteria):* Blockers section provides RPN-threshold criteria. An agent can determine dispositions without arbitrary judgment.

*Gap C resolved (Priority 5 from v2 — SEC-008 priority):* SEC-008 is labeled "(RPN 144, QG-E5 condition — **recommend REMEDIATE**)," making it immediately identifiable as a QG-E5 gating condition with a concrete recommendation.

**No remaining blocking actionability gaps.** The document provides: what to do (Task), where to write results (Expected Output with explicit paths), how to decide (Blockers criteria with RPN thresholds), what to prioritize (correct descending-RPN ordered list with recommendations for key findings), and what constitutes success (Success Criteria). The minor gap — SEC-005/007/010 lacking explicit recommendations — does not block action since the criteria enable derivation.

---

### Traceability (0.91/1.00)

**Evidence of improvement (since v2):**

*Gap A resolved (Priority 3 from v2 — QG-R2 traceability):* Line 49 adds `red/phase-2/red-recon-001/qg-r2-score.md`, closing the RED Phase 2 chain break.

**Traceability chain status (v3):**

| Chain | Status |
|-------|--------|
| VULN-001 through VULN-005 → SEC IDs | Complete (VULN ID column) |
| ENG Phase 1-5 outputs → QG scores → artifact paths | Complete |
| RED Phase 2 output → QG-R2 score → artifact path | Complete (resolved in v3) |
| RED Phase 3 output → QG-R3 score → artifact path | Complete |
| Acceptance criteria → source spec (synthesis spec Section 3) | Complete |
| Registration format → source standard (agent-routing-standards.md) | Complete |
| QG-E5 CONDITIONAL PASS conditions → Success Criterion #5 | Complete (new in v3) |
| Tool Tier CLEAN claim → verification artifact section | Indirect (section named, path via table lookup) |
| "—" VULN ID convention → explanation | Broken (no footnote) |
| QG-E3 "structurally verified" → methodology definition | Broken (no definition) |
| QG-V1/QG-V2 labels in Key Finding #5 → correspondence to QG-E5 iterations | Ambiguous (labeling inconsistency) |

**Remaining gaps:**

*Gap A (minor): "—" VULN ID convention not documented.* Without a convention note, a compliance matrix reviewer cannot confirm whether "—" means ENG-originated finding or simply un-cross-referenced.

*Gap B (minor): QG-V1/QG-V2 label inconsistency.* Key Finding #5 cites "QG-V1 (0.934), QG-V2 (0.943)" while the artifact table uses "QG-E5 score" for the iteration-2 result at 0.943. The correspondence between QG-V1/V2 and QG-E5 scoring iterations is not stated.

**Improvement Path:**
Add a footnote to the remediation table explaining the "—" VULN ID convention. Align QG labeling or add a note: "QG-V1/QG-V2 = ENG Phase 5 scoring iterations 1 and 2."

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Completeness / Methodological Rigor | 0.90 | 0.93 | Define "structurally verified" for QG-E3 in the artifact table — one sentence (e.g., "eng-backend-001/002/003: confirmed all 16 files reviewed for H-34/H-35 schema field presence; full S-014 scoring applied to 004a/004b only"). Resolves the undefined qualifier in both Completeness and Methodological Rigor. |
| 2 | Evidence Quality / Traceability | 0.88 / 0.91 | 0.92 | Add a footnote below the remediation table: "— = ENG-originated finding; no RED team counterpart. Traceability is to eng-security-001 security review only." One-line addition; resolves "—" convention gap in both dimensions. |
| 3 | Methodological Rigor | 0.90 | 0.93 | Add explicit ACCEPTED-RISK recommendations for SEC-005, SEC-007, and SEC-010 in the Blockers priority list (all three RPN values 50-100). E.g., append: "SEC-005 (RPN 96), SEC-010 (RPN 72), SEC-007 (RPN 64) — recommend ACCEPTED-RISK per criteria above." |
| 4 | Internal Consistency | 0.90 | 0.93 | Add RPN value to SEC-009 Residual Risk column: "Shares FM-05 root cause — RPN 192 (equivalent)." Aligns with the RPN-based format used by all other ACCEPTED-RISK rows. |
| 5 | Traceability | 0.91 | 0.93 | Align QG-V1/QG-V2 labeling: add "(= QG-E5 scoring iterations v1 and v2)" to Key Finding #5, or update to "QG-E5-v1 (0.934), QG-E5-v2 (0.943)" to match artifact table labeling. |

---

## Leniency Bias Check

- [x] Each dimension scored independently before composite computed
- [x] Evidence documented for each score with specific line and content references
- [x] Uncertain scores resolved downward: Evidence Quality held at 0.88 (not 0.90) because the "—" convention gap and indirect tool tier citation are real gaps, even if minor; Traceability held at 0.91 (not 0.92) because two minor chain issues remain
- [x] Revision-cycle calibration considered — iteration 3; all five Priority improvements from v2 were implemented; score improvement (+0.044) reflects genuine targeted improvements, not inflation
- [x] No dimension scored above 0.92; Actionability at 0.92 is the highest score, justified by complete resolution of all three prior actionability gaps with no blocking gaps remaining
- [x] False-positive from prior draft corrected: the ordering inconsistency finding was invalid against the current document; the scoring reflects the actual current state
- [x] Mathematical verification: (0.90 × 0.20) + (0.90 × 0.20) + (0.90 × 0.20) + (0.88 × 0.15) + (0.92 × 0.15) + (0.91 × 0.10) = 0.180 + 0.180 + 0.180 + 0.132 + 0.138 + 0.091 = 0.901
- [x] Calibration anchor check: 0.901 sits between 0.85 ("strong work, minor refinements needed") and 0.92 ("genuinely excellent"). Five distinct minor gaps hold the composite below threshold, none individually large but collectively sufficient to keep the score 0.019 below 0.92.

---

## Session Context (Handoff Schema)

```yaml
verdict: REVISE
composite_score: 0.901
prior_score: 0.857
score_delta: +0.044
threshold: 0.92
gap_to_threshold: -0.019
weakest_dimension: Evidence Quality (0.88)
critical_findings_count: 0
iteration: 3
improvement_recommendations:
  - "Define 'structurally verified' for QG-E3 in artifact table — one sentence describing methodology (affects Completeness + Methodological Rigor)"
  - "Add VULN ID dash convention footnote to remediation table: '— = ENG-originated finding; no RED team counterpart' (affects Evidence Quality + Traceability)"
  - "Add explicit ACCEPTED-RISK recommendations for SEC-005, SEC-007, SEC-010 in Blockers priority list (all three RPN values 50-100 per stated criteria)"
  - "Add RPN value to SEC-009 Residual Risk column: 'Shares FM-05 root cause — RPN 192 (equivalent)'"
  - "Align QG-V1/QG-V2 labeling in Key Finding #5 with QG-E5 iteration labeling used in artifact table"
```

---

*Scoring agent: adv-scorer*
*Agent version: 1.0.0*
*Constitutional compliance: P-001 (evidence-based scoring), P-002 (report persisted), P-003 (no subagents spawned), P-022 (leniency bias actively counteracted)*
